reports
Titan Medical to Issue Second Quarter 2022 Financial Results on August...
Titan Medical to Issue Second Quarter 2022 Financial Results on August 11, 2022 Webcast to Follow Announcement TORONTO, July 25, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on single access robotic-assisted surgery (RAS), today announced that the company plans to issue its second quarter 2022 financial results prior to market opening on Thursday, August 11, 2022. In addition, management will host an investor audio webcast at 8:30 a.m. ET to discuss financial results and business developments in the period. Speakers will incl...
Titan Medical Announces Appointment of Cary G. Vance as President and ...
Titan Medical Announces Appointment of Cary G. Vance as President and Chief Executive Officer TORONTO, June 30, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced that Cary G. Vance has been appointed as the company’s President and CEO effective July 1, 2022. Mr. Vance will succeed Paul Cataford, Titan’s chair of the board of directors, who has served as Interim President and CEO since December 20...
Titan Medical Provides Update to Enos Project Timeline
Titan Medical Provides Update to Enos Project Timeline De Novo marketing authorization planned for early 2025 remains unchanged TORONTO, June 28, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced that multiple disruptions have resulted in an updated Investigational Device Exemption (IDE) submission timeline for the Enos™ robotic single access surgery system. The company now expects the IDE subm...
Titan Medical Announces Agreement with Nissha Medical Technologies
Titan Medical Announces Agreement with Nissha Medical Technologies TORONTO, ON, June 21, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced that it has signed an agreement with Nissha Medical Technologies for the manufacture of surgical consumables. These single-use surgical components will be used for verification and validation testing, and pre-clinical and clinical studies of Titan’s Enos™ robo...
Titan Medical Achieves all Third Quarter Milestones Related to the Dev...
Titan Medical Achieves all Third Quarter Milestones Related to the Development of the SPORT Surgical System TORONTO, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in single-port minimally invasive surgery (“MIS”), announces that the Company has achieved all of its publicly stated third quarter 2018 development milestones for the SPORT Surgical System, as follows: Completed the improved camera insertio...
Titan Medical and Mimic Technologies Announce Successful Completion of...
Titan Medical and Mimic Technologies Announce Successful Completion of Core Surgical Skills Simulation Modules TORONTO and SEATTLE, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in single-port minimally invasive surgery (“MIS”) and Mimic Technologies Inc. (“Mimic”), a market leader in robotic simulation, announce the successful completion of the core surgical skills simulation modules for use with Titan’s...
Titan Medical to Webcast Business Update and Outlook Conference Call o...
Titan Medical to Webcast Business Update and Outlook Conference Call on September 20, 2018 TORONTO, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announced today that it will provide a live webcast of its business update and outlook conference call on Thursday, September 20th, beginning at 5:00 p.m. Eastern time. Speakers on the call will include David J. McNally, ...
Abstract Featuring Titan Medical’s SPORT Surgical System Presented a...
Abstract Featuring Titan Medical’s SPORT Surgical System Presented at the European Association of Urology Robotic Urology Section Annual Meeting TORONTO, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in single-port minimally invasive surgery (“MIS”), announces an abstract of a pilot study featuring the use of its SPORT Surgical System in partial nephrectomy and heminephrectomy procedures was presented a...
Titan Medical Granted U.S. Patent for Instrument Insertion and Positio...
Titan Medical Granted U.S. Patent for Instrument Insertion and Positioning in Single-Port Robotic Surgery TORONTO, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (TSX: TMD) (Nasdaq: TMDI) (“Titan” or the “Company”), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces that it has been granted U.S. Patent No. 10,058,396, titled “System and Apparatus for Insertion of an Instrument Into a Body Cavity for Performing a Surgical Procedure.” The patent covers technology that advances the...
Titan Medical to Present at Two Investment Conferences in September
Titan Medical to Present at Two Investment Conferences in September TORONTO, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (TSX: TMD) (Nasdaq: TMDI) (“Titan” or the “Company”), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (“MIS”), today announced that David McNally, President and CEO, will present a corporate overview at two upcoming investment conferences, as follows: 20th Annual Rodman & Renshaw Global Investment Conference Date and Time: Wednesday, September 5, 2018 at 12:30 p.m. East...
Titan Medical Reports Second Quarter 2018 Financial Results
Titan Medical Reports Second Quarter 2018 Financial Results TORONTO, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (TSX: TMD) (NASDAQ: TMDI) (“Titan” or “the Company”), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces financial results for the three months ended June 30, 2018. All financial results are prepared in accordance with International Financial Reporting Standards (“IFRS”) and are reported in U.S. dollars, unless otherwise stated. The unaudited condensed interim fin...
Titan Medical Announces Closing of Previously Announced Public Offerin...
Titan Medical Announces Closing of Previously Announced Public Offering TORONTO, Aug. 10, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (NASDAQ:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), is pleased to announce the closing of its previously announced public offering (the “Offering”) pursuant to an agency agreement dated August 7, 2018 between the Company and Bloom Burton Securities Inc. (the “Agent”). The Company completed t...
Titan Medical Announces Filing of Final Prospectus and Pricing of Mark...
Titan Medical Announces Filing of Final Prospectus and Pricing of Marketed Offering of Units TORONTO, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (NASDAQ:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), is pleased to announce today that it has filed and been receipted for a final short form prospectus (the “Final Prospectus”) in connection with the previously announced marketed offering (the “Offering”) of units of the Co...
Titan Medical Expands Advisory Role for Dr. Arnold Advincula to Includ...
Titan Medical Expands Advisory Role for Dr. Arnold Advincula to Include Clinical Education and Hospital Economics TORONTO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (NASDAQ: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in single-port minimally invasive surgery (“MIS”), announces an expanded advisory role for Arnold Advincula, M.D. encompassing clinical education and hospital economics. Dr. Advincula has served on Titan’s Surgeon Advisory Board since 20...
Titan Medical Announces Achievement of all Second Quarter 2018 SPORT S...
Titan Medical Announces Achievement of all Second Quarter 2018 SPORT Surgical System Development Milestones TORONTO, July 09, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (NASDAQ:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in single-port minimally invasive surgery (“MIS”), announces the achievement of all second quarter 2018 development milestones for its SPORT Surgical System. The Company previously provided expectations for incremental milestones as it develop...
Titan Medical Announces Marketed Offering of Units
Titan Medical Announces Marketed Offering of Units TORONTO, June 28, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (NASDAQ:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces today that it has filed and been receipted for a preliminary short form prospectus (the “Preliminary Prospectus”) with securities regulators in the provinces of Ontario, British Columbia and Alberta, and a corresponding registration statement on Form F-1...
Titan Medical Appoints Medtech Industry Veteran Domenic Serafino to It...
Titan Medical Appoints Medtech Industry Veteran Domenic Serafino to Its Board of Directors TORONTO, June 28, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces the appointment of Domenic Serafino to its board of directors, effective June 28. Mr. Serafino has held executive positions with various Canadian medical technology companies for more than 20 years. His appointme...
Titan Medical Common Stock to Trade on Nasdaq
Titan Medical Common Stock to Trade on Nasdaq TORONTO, June 27, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), today announced that shares of its common stock were approved for listing on the Nasdaq Capital Market. Titan Medical’s common stock will commence trading on the Nasdaq Capital Market on June 27, 2018 under the symbol TMDI. Titan Medical’s common stock will continue t...
Titan Medical’s Head of Intellectual Property Recognized as a Global...
Titan Medical’s Head of Intellectual Property Recognized as a Global IP Strategy Leader by Intellectual Asset Management TORONTO, June 20, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (OTCQB:TITXD), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery, announces that Jasminder Brar, Titan Medical’s Director of Strategic Development and Intellectual Property, was recognized by Intellectual Asset Management (IAM) as a global IP strategy leader. IAM, a ...
Titan Medical Announces Completion of 1-for-30 Reverse Stock Split
Titan Medical Announces Completion of 1-for-30 Reverse Stock Split TORONTO, June 19, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (OTCQB:TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery, announces that it has completed the previously announced consolidation (the “Consolidation”) of its outstanding common shares (the “Common Shares”) on the basis of the ratio of 1 post-Consolidation Common Share for 30 pre-Consolidation Common Shares. The C...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.